OSSTEC closes $8 million to fund the first-in-human U.S. launch of its ASCENT cementless partial knee system. The round was led by EMBRYO Ventures and includes investments from several prominent venture capital firms.
OSSTEC, an orthopedic company, has successfully closed an $8 million funding round. This capital will support the first-in-human surgical cases of its ASCENT cementless partial knee system in the U.S. The funding round was led by EMBRYO Ventures, alongside notable participation from other investors. The ASCENT system is designed to improve outcomes for partial knee replacement patients.
Who to call at OSSTEC, and when
A new round usually means OSSTEC is about to hire and buy. The teams that reach out first get the meeting.
An alert the day OSSTEC raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at OSSTEC, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OSSTEC. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
OSSTEC
Location
London, England, United Kingdom
About
OSSTEC is a London-based startup developing 3D printing technology for joint replacement implants, particularly focusing on cementless knee replacements. Founded on research from Imperial College London, the company aims to address challenges faced by traditional knee replacements, enhancing patient outcomes and operational efficiency. Its innovative approach stimulates bone growth and reduces implant failure risks, making it a significant advancement in orthopaedics. OSSTEC prioritizes collaboration with medical professionals to ensure the efficacy of its products.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment OSSTEC raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
LondonManufacturing